Evidence map›Paper›PMID 27340174›Full record

ArticleGenes & development2016

Proteomic analysis reveals GIT1 as a novel mTOR complex component critical for mediating astrocyte survival.

Laura J Smithson, David H Gutmann

Abstract read
In one paragraph

Article in Genes & development, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. The role of mTOR in age-related diseases.Journal of enzyme inhibition and medicinal chemistry · 2021
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Laura J SmithsonDepartment of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
David H GutmannDepartment of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a critical regulator of cell growth, the mechanistic target of rapamycin (mTOR) protein operates as part of two molecularly and functionally distinct complexes. Herein, we demonstrate that mTOR complex molecular composition varies in different somatic tissues. In astrocytes and neural stem cells, we identified G-protein-coupled receptor kinase-interacting protein 1 (GIT1) as a novel mTOR-binding protein, creating a unique mTOR complex lacking Raptor and Rictor. Moreover, GIT1 binding to mTOR is regulated by AKT activation and is essential for mTOR-mediated astrocyte survival. Together, these data reveal that mTOR complex function is partly dictated by its molecuflar composition in different cell types.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsAstrocytesCell Cycle ProteinsCells, CulturedCell SurvivalEnzyme ActivationGene Expression RegulationGene Knockdown TechniquesGTPase-Activating ProteinsHEK293 CellsHumansMiceNeurofibromin 1Protein BindingProteomicsAdaptor Proteins, Signal TransducingCell Cycle ProteinsGIT1 protein, humanGit1 protein, mouseGTPase-Activating ProteinsMTOR protein, humanmTOR protein, mouseNeurofibromin 1Proto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesastrocytesbrainGIT1mTOR

Identifiers

PMID27340174
PMCPMC4926861

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.